2022/6/15
塩野義製薬は15日、AMR（薬剤耐性菌）治療薬セフィデロコル（一般名）について、低中所得国を中心に同剤へのアクセスを拡大するため「GARDP」とライセンス契約を結んだと発表した。
Antimicrobial resistance, one of the world’s biggest killers, has reached an alarming tipping point.
Changing the way antibiotics are developed and accessed.
A public-health driven model to tackle AMR.
Our latest news and resources.
Protecting people from the rise and spread of drug-resistant infections.
Supporting efforts to ensure the right antibiotics are developed and reach the people who need them.